Patient centred outcomes in osteoarthritis
Open Access
- 1 January 2005
- journal article
- leader
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 64 (1) , 1-2
- https://doi.org/10.1136/ard.2004.025072
Abstract
Osteoarthritis (OA) is the most common joint disorder in the world; it occurs in the majority of people over the age of 65 and is an important cause of (work) disability. The public health impact of OA is immense and will further increase with the growing elderly population. Therefore, the search for, and evaluation of, treatments for OA are relevant research topics, not only for the medical community, including individual patients and doctors, but also for pharmaceutical companies and health economists. Assessment of present and future treatment modalities in OA is important and requires a balanced approach.1Keywords
This publication has 9 references indexed in Scilit:
- Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom stateAnnals of the Rheumatic Diseases, 2005
- Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvementAnnals of the Rheumatic Diseases, 2005
- EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)Annals of the Rheumatic Diseases, 2003
- OMERACT 6 brings new perspectives to rheumatology measurement research.2003
- Outcomes from the Patient Perspective Workshop at OMERACT 6.2003
- Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III.1997
- Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteriaArthritis & Rheumatism, 1996
- Concordant and discrepant views of patients' physical functioningArthritis & Rheumatism, 1995
- What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?1995